CSPG4 and fibrosarcoma: Given that the NG2–collagen VI interaction was shown to activate pro-survival and pro-migratory pathways in the HT1080 fibrosarcoma model as revealed by antibody arrays, these pathways could serve as potential targets for future therapeutic intervention for this STS subtype.